Company Comparison
Moderna vs BioAnalytics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Moderna | BioAnalytics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | Boston |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $55M |
| Valuation | — | — |
What They Build
Moderna
Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
BioAnalytics
Boston-based biotech company developing analytics and data solutions for the life sciences industry.
Key Investors
Moderna
BioAnalytics
No investors listed.
Sector Overlap
Both Moderna and BioAnalytics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.